Persistent reservations against contradicted percutaneous coronary intervention indications: Citation content analysis

American Heart Journal

Volumn 157, Issue 4, 2009, Pages 695-701

  Siontis, George C M ^a   Tatsioni, Athina ^a,b   Katritsis, Demosthenes G ^c   Ioannidis, John P A ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Athens Euroclinic ^*  (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTHOR; BARE METAL STENT; CARDIOLOGIST; CITATION ANALYSIS; CONSERVATIVE TREATMENT; EVALUATION; OUTCOME ASSESSMENT; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; TREATMENT INDICATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; HUMANS; ODDS RATIO; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 62949117003     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.11.023     Document Type: Article

References (36)

1. Rosamond W., Flegal K., Furie K., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
2. Boden W.E., O'Rourke R.A., Teo K.K., et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007) 1503-1516
3. Hochman J.S., Lamas G.A., Buller C.E., et al. Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 355 (2006) 2395-2407
4. Hachamovitch R., Hayes S.W., Friedman J.D., et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 107 (2003) 2900-2907
5. Coolong A., Baim D.S., Kuntz R.E., et al. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 117 (2008) 790-797
6. Hoye A., van Domburg R.T., Sonnenschein K., et al. Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002. Eur Heart J. 26 (2005) 2630-2636
7. Olivari Z., Rubartelli P., Piscione F., et al. TOAST-GISE Investigators. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE). J Am Coll Cardiol 41 (2003) 1672-1678
8. Kim C.B., and Braunwald E. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation 88 (1993) 2426-2436
9. Counsell C. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med. 127 (1997) 380-387
10. Kereiakes D.J. Interpreting the COURAGE trial. PCI is no better than medical therapy for stable angina? Seeing is not believing. Cleve Clin J Med 74 (2007) 637-638
11. Kereiakes D.J., Teirstein P.S., Sarembock I.J., et al. The truth and consequences of the COURAGE trial. J Am Coll Cardiol. 50 (2007) 1598-1603
12. Hachamovitch R., and Di Carli M.F. Nuclear cardiology will remain the "gatekeeper" over CT angiography. J Nucl Cardiol. 14 (2007) 634-644
13. Bhatt D.L. Interpreting the COURAGE trial. Is medical therapy as good as PCI in stable angina? Two views. Cleve Clin J Med 74 (2007) 618-620
14. Gerber T.C., Kantor B., and Chareonthaitawee P. Coronary computed tomographic angiography and exercise electrocardiography: a great match or unequal partners?. Eur Heart J. 28 (2007) 1787-1789
15. Beohar N., Davidson C.J., Kip K.E., et al. Off-label use of drug-eluting stents. JAMA 298 (2007) 859-860
16. Erne P., Schoenenberger A.W., Burckhardt D., et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA. 297 (2007) 1985-1991
17. Mark D.B. Percutaneous coronary revascularisation: is it ever worth what it costs?. Heart. 93 (2007) 1161-1163
18. Bangalore S., and Messerli F.H. Is there an ischemic threshold beyond which percutaneous coronary intervention is beneficial in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial?. Am J Cardiol. 100 (2007) 1495
19. Satler L. Angiography during PFO closure: "a glimpse of the future". Catheter Cardiovasc Interv. 70 (2007) 646
20. Anderson J.R. Persistent coronary occlusion after myocardial infarction. N Engl J Med. 356 (2007) 1681
21. Conti C.R. Some patients with persistent coronary artery occlusion after acute myocardial infarction may require revascularization. Clin Cardiol 30 (2007) 371-372
22. Shiraishi J., Kohno Y., Sawada T., et al. AMI-Kyoto Multi-Center Risk Study Group. In-hospital outcomes of primary percutaneous coronary interventions performed at hospitals with and without on-site coronary artery bypass graft surgery. Circ J 71 (2007) 1208-1212
23. Hillis L.D., and Lange R.A. Myocardial infarction and the open-artery hypothesis. N Engl J Med. 355 (2006) 2475-2477
24. Hochman J.S., Lamas G.A., Knatterud G.L., et al. Occluded Artery Trial Research Group. Design and methodology of the Occluded Artery Trial (OAT). Am Heart J 150 (2005) 627-642
25. Rothwell P.M., Mehta Z., Howard S.C., et al. Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet. 365 (2005) 256-265
26. Rothwell P.M. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365 (2005) 176-186
27. Mauri L., Silbaugh T.S., Wolf R.E., Zelevinsky K., Lovett A., Zhou Z., Resnic F.S., and Normand S.L. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation. 118 (2008) 1817-1827
28. Mark D.B., Knight J.D., Cowper P.A., Davidson-Ray L., and Anstrom K.J. Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) trial. Am Heart J. 156 (2008) 698-705
29. American Board of Internal Medicine Certification Examination. Available at: http://www.abim.org/resources/statcert.shtm. Last accessed March 18, 2008.
30. Bekelman J.E., Li Y., and Gross C.P. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289 (2003) 454-465
31. Als-Nielsen B., Wendong C., Gluud C., et al. Association of funding and conclusions in randomized drug trials. JAMA 290 (2003) 921-928
32. Tatsioni A., Bonitsis N.G., and Ioannidis J.P. Persistence of contradicted claims in the literature. JAMA. 298 (2007) 2517-2526
33. Katritsis D.G., and Ioannidis J.P. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation. 111 (2005) 2906-2912
34. Ioannidis J.P., and Katritsis D.G. Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients. Am Heart J. 154 (2007) 1065-1071
35. Katritsis D.G., and Ioannidis J.P. PCI for stable coronary disease. N Engl J Med. 357 (2007) 414-415
36. Abbate A., Biondi-Zoccai G.G., Appleton D.L., et al. Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 51 (2008) 956-964